2024 Spring International Convention of
The Pharmaceutical Society of Korea

2024 Spring
International Convention of PSK

04.17(WED) - 04.19(FRI)
D+28

Abstracts

P7-5

Comparison of volatile composition and anti-inflammatory activity of four Asteraceae family essential oils

  • Hyunjeong Na1, Mi-Jin Park*1, Nahyun Kim1, Soo-Kyeong Jang1, Jeongha Yoon1, Chanjoo Park1
  • 1Forest Industrial Materials Division, Forest Products and Industry Department, National Institute of Forest Science, Korea

Excessive inflammatory reaction worsen various human diseases. Essential oils have the advantage as medicine because there is no risk of long-term genotoxicity. Asteraceae family have been used for the medicine from the past, and their bioactivities have been reported. In this study, the anti-inflammatory activity and the volatile composition of Asteraceae family essential oils were compared with each other to select candidate that are relatively safe and effective. The four essential oils used in this study were Artemisia capillaris, Aster glehnii, Dendranthema indicum, and Dendranthema zawadskii. The essential oils was extracted by hydro-distillation. The chemical composition was analyzed by GC-MS. The anti-inflammatory effect was evaluated by observing changes in the expression level of genes(IL-4, IL-5, IL-6, IL-13, TNF-α, and COX-2) involved in the inflammatory response. In evaluating anti-inflammatory activity, the activities were good in that order; A. capillaris, D. zawadskii, A. glehnii, and D. indicum. All essential oils significantly reduced IL-5, IL-6, and COX-2. But, D. indicum did not produce significant changes in IL-4, IL-13, and TNF-α. On the other hand, A. capillaris significantly reduced the expression level of six genes. According to GC-MS analysis, it was confirmed that the main components of A. capillaris are α-farnesene(33.6%), caryophyllene(19.5%), and β-pinene(8.0%), respectively. These results suggest that among Asteraceae family, A. capillaris might have a higher potential for the use as an anti-inflammatory product.​


Q&A

작성하기
  • There are no registered questions
TODAY 2024. 05. 17

2024 Spring Convention

D+28

Conference infomation

Conference Schedule
Apr. 17(Wed) ~ 19(Fri), 2024
Conference Venue
BPEX (Busan Port International Exhibition & Convention Center) Busan Metropolitan City, Republic of Korea
Location
Early Registration Period
Feb. 20(Tue) ~ Apr. 3(Wed), 2024
Abstract Submission Period
Feb. 20(Tue) ~ Apr. 3(Wed), 2024
Certificate of Attendance